Roledumab, initially known as LFB-R593, represents a innovative therapeutic strategy targeting specific features of autoimmune disease. This antibody demonstrates substantial efficacy in preclinical research, particularly concerning reducing inflammatory responses. Researchers suggest its mechanism of action, involving specifically preventing certa

Carotuximab, also known as TRC105 or DE-122, represents a emerging antibody-drug conjugate therapeutic currently under investigation for combating various malignant conditions. This specific molecule selects a defined antigen, expressed on cancer cells, releasing a powerful cytotoxic payload directly within the affected area. Early clinical assessm

S2H97 Antibody: The Powerful Resource for the Coronavirus Study The S2H97 serum factor offers the critical asset for advancing understanding into the virus. Its function to specifically recognize the SARS-CoV-2 spike protein allows it invaluable for multiple uses, including assessment in the virus, neutralization infection, and creation of novel t